Litigation finance is the funding of legal claims by outside investors in exchange for a share of any recovery. The capital is typically non-recourse — if the case loses, the funder loses its investment and the claimant owes nothing — making each funded case a binary-ish, uncorrelated bet on legal merits, and the portfolio of them an asset class.
How the strategy works
The core commercial trade: a funder pays a claimant’s legal costs (or advances working capital against the claim) in return for a negotiated recovery share — commonly structured as a multiple of invested capital, a percentage of proceeds, or the greater of the two, escalating with time. Deal types span single-case commercial funding, portfolio facilities to law firms or corporates secured by baskets of cases (the diversification that moved the industry from wagers toward asset management), claim monetization (advancing value against won-but-unpaid judgments and awards), and specialist niches — international arbitration, patent enforcement, bankruptcy estates, mass torts. Consumer pre-settlement advances are the retail cousin: economically related, regulatorily and reputationally distinct.
The investment case and its frictions. The appeal is genuine non-correlation — case outcomes don’t track markets — plus historically attractive gross multiples on won cases. The frictions are equally structural: duration risk dominates (litigation timelines are unpredictable and appeal-extendable, so IRRs erode while multiples hold — the industry’s recurring investor complaint), outcomes are lumpy and binary at the case level, valuation of unresolved claims is judgment stacked on judgment (fair-value marks on pending cases deserve the same skepticism as any RVPI-heavy book), and collection risk survives victory — winning a judgment and collecting it are different events. The legal-system overlay is the asset class’s unique risk stratum: enforceability doctrines vary by jurisdiction, disclosure-of-funding rules are actively evolving, and fee-sharing and control ethics constrain deal design — funders finance cases but may not control them.
Access for advised clients: dedicated litigation funds (drawdown GP/LP structures suit the duration), listed funders, multi-strategy credit sleeves, and occasional interval-fund exposure. Diligence weights the manager’s underwriting infrastructure (case selection is the alpha), realized track record separating won-and-collected from marked, deployment discipline against the sector’s episodic capital floods, and honest duration expectations set with the client before the first extension of the first appeal.
FAQ
What is litigation finance in simple terms?
Investors pay a lawsuit’s costs in exchange for a cut of the winnings — and if the case loses, the claimant typically owes nothing.
Why do investors like litigation finance?
Court outcomes don’t correlate with markets, and won cases have historically paid attractive multiples — genuine diversification, priced in duration and binary risk.
What's the biggest risk in litigation funding?
Time, then judgment: cases run long and unpredictably (eroding annualized returns), interim valuations are soft, and even victories must still be collected.
Related terms
Alternative Investment · Royalty Financing · Distressed Debt · RVPI · GP / LP Structure
Educational content only; not investment, tax, or legal advice. Consult qualified professionals regarding your specific circumstances.
